Clostridium difficileinfection: update on emerging antibiotic treatment options and antibiotic resistance
- 1 May 2010
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Anti-infective Therapy
- Vol. 8 (5), 555-564
- https://doi.org/10.1586/eri.10.28
Abstract
Clostridium difficile infection (CDI) is the most common cause of identifiable diarrhea in hospitalized patients. The incidence and severity of CDIs are increasing. The increased incidence and seve...Keywords
This publication has 44 references indexed in Scilit:
- Clostridium difficile ribotypes 027 and 106: clinical outcomes and risk factorsJournal of Hospital Infection, 2009
- Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolatesClinical Microbiology & Infection, 2007
- In Vitro Activities of 15 Antimicrobial Agents against 110 Toxigenic Clostridium difficile Clinical Isolates Collected from 1983 to 2004Antimicrobial Agents and Chemotherapy, 2007
- Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanideJournal of Antimicrobial Chemotherapy, 2007
- In Vitro Activity of Ramoplanin against Clostridium difficile , Including Strains with Reduced Susceptibility to Vancomycin or with Resistance to MetronidazoleAntimicrobial Agents and Chemotherapy, 2005
- Activity of OPT-80, a Novel Macrocycle, Compared with Those of Eight Other Agents against Selected Anaerobic SpeciesAntimicrobial Agents and Chemotherapy, 2004
- Rifalazil Treats and Prevents Relapse of Clostridium difficile -Associated Diarrhea in HamstersAntimicrobial Agents and Chemotherapy, 2004
- In vitro activity of ramoplanin and comparator drugs against anaerobic intestinal bacteria from the perspective of potential utility in pathology involving bowel floraAnaerobe, 2004
- Reassessment of Clostridium difficile Susceptibility to Metronidazole and VancomycinAntimicrobial Agents and Chemotherapy, 2002
- Comparative in vitro activity of BAY 12-8039 and five other antimicrobial agents against anaerobic bacteriaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1998